Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Handberg

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Circulation. Cardiovascular Quality and Outcomes|December 9, 2017
Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation)Tanya S Kenkre, Pankaj Malhotra, B Delia Johnson, et al.
Journal of the American College of Cardiology|December 20, 2005
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device functionJuan M Aranda, Gregory W Woo, Richard S Schofield, et al.
Clinical Cardiology|November 24, 2004
Characteristics of contemporary patients with hypertension and coronary artery diseaseRhonda M Cooper-DeHoff, Eileen M Handberg, Jerome Cohen, et al.
American Heart Journal|June 4, 2014
Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluationAnthony A Bavry, Eileen M Handberg, Tianyao Huo, et al.
Plos One|May 8, 2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)John W Petersen, B Delia Johnson, Kevin E Kip, et al.
Cardiovascular Endocrinology|December 15, 2015
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation StudyAsma Khaliq, B Delia Johnson, R David Anderson, et al.
Journal of Clinical Pharmacology|August 10, 2016
Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam PharmacokineticsMarina Kawaguchi-Suzuki, Negar Nasiri-Kenari, Jonathan Shuster, et al.
American Journal of Hypertension|September 20, 2008
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)R David Anderson, B Clay Sizemore, Genevieve M Barrow, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Antihypertensive medication adherence trends by sex and drug class: A pilot studyHenry Reed Holmes, Qian Li, Ke Xu, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Circulation. Cardiovascular Quality and Outcomes|December 9, 2017
Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation)Tanya S Kenkre, Pankaj Malhotra, B Delia Johnson, et al.
Journal of the American College of Cardiology|December 20, 2005
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device functionJuan M Aranda, Gregory W Woo, Richard S Schofield, et al.
Clinical Cardiology|November 24, 2004
Characteristics of contemporary patients with hypertension and coronary artery diseaseRhonda M Cooper-DeHoff, Eileen M Handberg, Jerome Cohen, et al.
American Heart Journal|June 4, 2014
Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluationAnthony A Bavry, Eileen M Handberg, Tianyao Huo, et al.
Plos One|May 8, 2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)John W Petersen, B Delia Johnson, Kevin E Kip, et al.
Cardiovascular Endocrinology|December 15, 2015
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation StudyAsma Khaliq, B Delia Johnson, R David Anderson, et al.
Journal of Clinical Pharmacology|August 10, 2016
Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam PharmacokineticsMarina Kawaguchi-Suzuki, Negar Nasiri-Kenari, Jonathan Shuster, et al.
American Journal of Hypertension|September 20, 2008
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE)R David Anderson, B Clay Sizemore, Genevieve M Barrow, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Antihypertensive medication adherence trends by sex and drug class: A pilot studyHenry Reed Holmes, Qian Li, Ke Xu, et al.
Women'S Health (London, England)|September 7, 2013
Clinical implications of the Women's Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomesEileen M Handberg, Jo-Ann Eastwood, Wafia Eteiba, et al.
Pageof 11